IconOVir Bio is a company headquartered in the United States.
IconOVir Bio is a biotechnology company developing antibody-drug conjugates (ADCs) to treat cancer by targeting and eliminating tumor cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.